Phase I trial with weekly EO9, a novel bioreductive...

Cancer Chemotherapy and Pharmacology 2000 / 01 Vol. 45; Iss. 1

Phase I trial with weekly EO9, a novel bioreductive alkylating indoloquinone, by the EORTC Early Clinical Study Group (ECSG)

S. Aamdal, B. Lund, I. Koier, M. Houten, J. Wanders, J. Verweij
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
45
Language:
english
Pages:
4
DOI:
10.1007/pl00006748
Date:
January, 2000
File:
PDF, 78 KB
english, 2000
Conversion to is in progress
Conversion to is failed